Skye Bioscience (SKYE) has released an update to notify the public and investors about the unregistered sales of equity securities.
The securities mentioned were sold in transactions not requiring registration under the Securities Act, relying on specific exemptions. Investors confirmed their accredited status and intention to acquire the securities for investment purposes only, not for distribution. These securities are not registered, thus cannot be sold in the U.S. without registration or an applicable exemption. Furthermore, this report does not constitute an offer to sell or a solicitation to buy any securities.
For further insights into SKYE stock, check out TipRanks’ Stock Analysis page.
